We are live on ! Find out more
NLVP

New Leaf Venture Partners Portfolio holdings

AUM $43M
1-Year Est. Return 25.55%
This Fund
S&P 500
This Quarter Est. Return
+10.35%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$142M
AUM Growth
-$52.8M
Cap. Flow
-$45.9M
Cap. Flow %
-32.23%
Top 10 Hldgs %
93.29%
Holding
16
New
–
Increased
4
Reduced
7
Closed
1

Top Buys

1
TRIL
Trillium Therapeutics Inc.
TRIL
+$1.66M
2
OTIC
Otonomy, Inc.
OTIC
+$263K
3
OBSV
ObsEva SA Ordinary Shares
OBSV
+$224K
4
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$193K

Top Sells

1
IRTC icon
iRhythm Holdings
IRTC
+$39.2M
2
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
+$2.99M
3
SAGE
Sage Therapeutics
SAGE
+$2.26M
4
ALDR
Alder Biopharmaceuticals
ALDR
+$1.05M
5
CRSP icon
CRISPR Therapeutics
CRSP
+$970K

Sector Composition

1 Healthcare 97.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRTC icon
1
iRhythm Holdings
IRTC
$3.79B
$28.3M 19.87%
665,965
-1,075,624
-62% -$39.2M
ARAV
2
DELISTED
Aravive, Inc. Common Stock
ARAV
$25.3M 17.75%
241,383
– –
PDSB icon
3
PDS Biotechnology
PDSB
$39.8M
$24.1M 16.9%
117,243
– –
OXFD
4
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$16M 11.25%
952,497
-200,000
-17% -$2.99M
WVE icon
5
Wave Life Sciences
WVE
$1.09B
$12.2M 8.6%
658,259
– –
CRSP icon
6
CRISPR Therapeutics
CRSP
$4.78B
$8.45M 5.94%
527,730
-58,745
-10% -$970K
AVEO
7
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$6.86M 4.82%
309,067
-100,000
-24% -$787K
SAGE
8
DELISTED
Sage Therapeutics
SAGE
$5.41M 3.8%
67,872
-31,251
-32% -$2.26M
SRRA
9
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$3.21M 2.26%
68,602
+3,787
+6% +$193K
DMTX
10
DELISTED
Dimension Therapeutics, Inc
DMTX
$2.99M 2.1%
2,059,283
– –
OTIC
11
DELISTED
Otonomy, Inc.
OTIC
$2.07M 1.45%
109,825
+18,875
+21% +$263K
OBSV
12
DELISTED
ObsEva SA Ordinary Shares
OBSV
$1.97M 1.38%
230,205
+30,205
+15% +$224K
ALDR
13
DELISTED
Alder Biopharmaceuticals
ALDR
$1.96M 1.38%
171,364
-57,064
-25% -$1.05M
DERM
14
DELISTED
Dermira, Inc.
DERM
$1.78M 1.25%
61,109
-5,000
-8% -$152K
TRIL
15
DELISTED
Trillium Therapeutics Inc.
TRIL
$1.78M 1.25%
404,159
+300,000
+288% +$1.66M
EVAR
16
DELISTED
Lombard Medical, Inc.
EVAR
– –
-1,072,634
Closed -$837K

Similar funds

BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

New Leaf Venture Partners's Q2 2017 Portfolio in Review

As of Q2 2017, New Leaf Venture Partners held 16 positions worth $142M, down 27% from $195M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

New Leaf Venture Partners withdrew a net $45.9M in Q2 2017, closing 1 position and reducing 7 holdings. Its most notable exit was Lombard Medical, Inc., an estimated $837K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 98% a quarter earlier.

Against the trend, New Leaf Venture Partners added an estimated $1.66M to Trillium Therapeutics Inc..

  • New Leaf Venture Partners added most to Trillium Therapeutics Inc. in Q2 2017, an estimated $1.66M increase.
  • New Leaf Venture Partners's biggest Q2 2017 reduction was iRhythm Holdings, cutting an estimated $39.2M.
  • New Leaf Venture Partners fully exited Lombard Medical, Inc. in Q2 2017, selling an estimated $837K.
  • New Leaf Venture Partners's ten largest holdings make up 93% of its $142M portfolio in Q2 2017.
  • New Leaf Venture Partners opened 0 new positions and closed 1 in Q2 2017.
  • New Leaf Venture Partners's portfolio value fell 27% quarter-over-quarter to $142M.

Based on New Leaf Venture Partners's 13F filing for Q2 2017, filed 14 Aug 2017.